A
Anselm K. Gitt
Researcher at Heidelberg University
Publications - 265
Citations - 13930
Anselm K. Gitt is an academic researcher from Heidelberg University. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 51, co-authored 261 publications receiving 12897 citations. Previous affiliations of Anselm K. Gitt include European Society of Cardiology & University of Cyprus.
Papers
More filters
Journal ArticleDOI
Gender differences in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock.
Oliver Koeth,Ralf Zahn,Tobias Heer,Timm Bauer,Claus Juenger,Bärbel Klein,Anselm K. Gitt,Jochen Senges,Uwe Zeymer +8 more
TL;DR: In women, STEMI was more often complicated by cardiogenic shock when compared to men, however, the use of early reperfusion therapy did not differ between the sexes.
Journal ArticleDOI
Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach
TL;DR: A combination therapy with aspirin, an ACE inhibitor and a statin reduces 1-year mortality in patients after AMI and a polypill approach with these three agents should be considered to increase drug compliance and reduce mortality after acute myocardial infarction.
Journal ArticleDOI
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.
Joost Daemen,Maarten L. Simoons,William Wijns,Adrian Bagust,Gert Bos,James M. Bowen,Eugene Braunwald,Edoardo Camenzind,Bernard Chevalier,Carlo DiMario,Jean Fajadet,Anselm K. Gitt,Giulio Guagliumi,Hans L. Hillege,Stefan James,Peter Jüni,Adnan Kastrati,Sabine Kloth,Steen Dalby Kristensen,Mitchell W. Krucoff,Victor Legrand,Matthias Pfisterer,Martin T. Rothman,Patrick W. Serruys,Sigmund Silber,Philippe Gabriel Steg,Ibrahim Tariah,Lars Wallentin,Stephan Windecker,A. Aimonetti,D. Allocco,A. Baczynska,A. Bagust,M. Berenger,G. Bos,A. Boam,J.M. Bowen,E Braunwald,J.P. Calle,E. Camenzind,G. Campo,S. Carlier,B. Chevalier,J. Daemen,J. de Schepper,G. Di Bisceglie,C. DiMario,H. Dobbels,J. Fajadet,Andrew Farb,J.C. Ghislain,A. Gitt,G. Guagliumi,S. Hellbardt,H.L. Hillege,R. ten Hoedt,C. Isaia,S. James,P. de Jong,P. Jüni,A. Kastrati,E. Klasen,S. Kloth,Steen Dalby Kristensen,M.W. Krucoff,V. Legrand,M. Lekehal,L. LeNarz,F. Ni Mhullain,H. Nagai,A. Patteet,D. Paunovic,M. Pfisterer,A. Potgieter,I. Purdy,C. Raveau-Landon,M. Rothman,P. W. Serruys,S. Silber,M. L. Simoons,P.G. Steg,I. Tariah,S. Ternstrom,J. Van Wuytswinkel,M. Waliszewski,L. Wallentin,W. Wijns,S Windecker +87 more
TL;DR: Key opinion leaders in (interventional) cardiology and representatives from industry and regulatory bodies gathered in the European Heart House with the intention to provide general recommendations to the medical community for the use, clinical development, and future assessment of DES.
Journal ArticleDOI
Inadequate control of heart rate in patients with stable angina: Results from the European Heart Survey
Caroline Daly,Felicity Clemens,José Luis López Sendón,Luigi Tavazzi,Eric Boersma,Nicolas Danchin,François Delahaye,Anselm K. Gitt,Desmond G. Julian,David Mulcahy,Witold Rużyłło,Kristian Thygesen,Freek W.A. Verheugt,Kim Fox +13 more
TL;DR: Control of ischaemic symptoms through heart rate modification in patients with angina is currently inadequate, both by primary referring physicians and cardiologists, and attention should be given to achieving optimal HR control.
Journal ArticleDOI
Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe
Jean Ferrières,Gaetano M. De Ferrari,Michel P. Hermans,Moses Elisaf,Peter P. Toth,Martin Horack,Philippe Brudi,Dominik Lautsch,Lori D. Bash,Carl A. Baxter,Veronica Ashton,Baishali M. Ambegaonkar,Anselm K. Gitt +12 more
TL;DR: Elevated blood cholesterol levels are highly prevalent across Europe, with low numbers of coronary patients reaching their recommended LDL-C target, and there is significant scope for intensifying treatment.